Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.
Yih-Ing HserYuhui ZhuZhe FeiLarissa J MooneyElizabeth A EvansAnnemarie KelleghanAbigail MatthewsCaroline YooAndrew J SaxonPublished in: Addiction (Abingdon, England) (2021)
Among adults with comorbid opioid use disorder and mental disorders, treatment with buprenorphine-naloxone produced greater reductions in opioid use than treatment with methadone.
Keyphrases